维普中文期刊产品整合服务
1100篇 您的检索式:作者名="Pas F"
    题名 作者 年代 出处 被引量
1螺内酯与可乐定作为难治性高血压第4种治疗药物的比较:难治性高血压的最佳治疗随机研究显示文摘该研究旨在通过一个多中心随机试验对作为难治性高血压患者的第4种治疗药物的螺内酯与可乐定进行比较。采用药丸计数评估药物治疗依从性。难治性高血压患者(定义为包括1种利尿剂在内的3种药物治疗12周,诊室及动态血压监测血压仍未控制)随机给予螺内酯(12.5~50 mg/d)或可乐定(0.1~0.3mg,2次/d)继续治疗12周。Krieger EM Drager LF Giorgi DMA Pereira AC Barreto-Filho JAS Nogueira AR Mill JG Lotufo PA Amodeo C Batista MC Bodanese LC Carvalho ACC Castro I Chaves H Costa EAS Feitosa GS Franco RJS Fuchs FD Guimarāes AC Jardim PC Machado CA Magalhāes ME Mion D Jr Nascimento RM Nobre F Nóbrega AC Ribeiro ALP Rodrigues-Sobrinho CR Sanjuliani AF Teixeira MDCB Krieger JE ReHOT Investigators 赵狄 练桂丽 2018中华高血压杂志2018,26,3:7
22013年美国心脏病学会/美国心脏协会胆固醇管理指南在美国心脏病学实践中的应用显示文摘2013年美国心脏病学会/美国心脏协会(American College of Cardiology/American Heart Association,ACC/AHA)胆固醇管理指南建议在符合治疗标准的患者中采用中等强度至高强度他汀类药物治疗。该研究的目的在于审查2013年ACC/AHA指南在美国心脏病学实践中的应用情况。刘莉 叶鹏 Pokharel Y Tang F Jones PG Nambi V Bittner VA Hira RS Nasir K Chan PS Maddox TM Oetgen WJ Heidenreich PA Borden WB Spertus JA Petersen LA Ballantyne CM Virani SS 2017中华高血压杂志2017,25,6:2
3卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景 缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 2017国际脑血管病杂志2017,25,5:2
4International Autoimmune Hepatitis Group Report:review of criteria for diagnosis of autoimmune hepatitis显示文摘Alvarez F Berg PA Bianchi FB Journal of Hepatology0,,:2
5胆固醇酯转移蛋白基因的蛋白质截断型变异体与冠状动脉性心脏病风险的关系显示文摘随机对照试验结果表明,抑制胆固醇酯转运蛋白(cholesteryl ester transfer protein,CETP)的疗法并不能降低冠状动脉性心脏病(coronary heart disease,CHD)的发生风险。研究失败的可能原因包括靶目标无效、靶目标外小分子的不良反应和随机对照设计因素影响等。在编码药物靶点的基因中具有天然存在的遗传变异,以此为基础,人类研究可以深入了解针对基因产物的治疗的潜在功效和安全性。Nomura A Won HH Khera AV Takeuchi F Ito K McCarthy S Emdin CA Klarin D Natarajan P Zekavat SM Gupta N Peloso GM Borecki IB Teslovich TM Asselta R Duga S Merlini PA Correa A Kessler T Wilson JG Bown MJ Hall AS Braund PS Carey DJ Murray MF Kirchner HL Leader JB Lavage DR Manus JN Hartze DN Samani NJ Schunkert H Marrugat J Elosua R McPherson R Farrall M Watkins H Juang JJ Hsiung CA Lin SY Wang JS Tada H Kawashiri MA Inazu A Yamagishi M Katsuya T Nakashima E Nakatochi M Yamamoto K Yokota M Momozawa Y Rotter JI Lander ES Rader DJ Danesh J Ardissino D Gabriel S Willer CJ Abecasis GR Saleheen D Kubo M Kato N Ida Chen YD Dewey FE Kathiresan S 刘莉 叶鹏 2017中华高血压杂志2017,25,9:2
6Short and long term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction显示文摘Lemos PA Saia F Hofma SH 2004J Am Coll Cardiol2004,43,4:1
7Sirolimus-eluting stent implantation in ST elevatioancute myocardial infarction:a clinical and anglographic study显示文摘Saia F Lemos PA Lee CH 2003Circulation2003,108,16:1
8Airway hyper-responsiveness in allergic asthma in guinea-pigs is mediated by nerve growth factor via the induction of substance P:a potential role for trkA 显示文摘DE-Vries A Engels F Henricks PA 2006Clin Exp Allergy2006,36,9:1
9Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposeition显示文摘Becker CD Barbier PA Terrier F 1987A JR1987,148,2:1
10Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reports显示文摘Domizio P Hall PA Cotter F 1989Hematol Oncol1989,7,:1
11查看详情显示文摘Pa N F C Ahmed I Nawawi M G M Rahman W A W A 0,,04:1
12Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro显示文摘Klemmt PA Liu F Carver JG 2009Hum Reprod2009,24,9:1
13Pre-clinical whole- body fluorescence imaging: review of instruments, methods and applications 显示文摘Leblond F Davis SC Vald6s PA 2010J Photochem Photobiol B2010,98,:1
14Local delivery of chlorhexidine gluconate (PerioChip) in periodontal maintenance patients显示文摘Heasman PA Heasman L Stacey F 2001J Clin Periodontol2001,28,1:1
15Transplantation of adipose tissue-deribed stromal cells increases mass and functional capacity of damaged skeletal muscel 显示文摘Bacou F Andalousi RB Daussin PA 2004Cell Transplant2004,13,2:1
16Asthmatic bronchial epithelial cellshave a deficient innate immune response to infection with rhinovirus显示文摘Wark PA Johnston SL Bucchieri F 2005J Exp Med2005,201,6:1
17Completion surgery after con-comitant chemoradiation in obese women with locally advanced cerv-ical cancer:Evaluation of toxicity and outcome measures显示文摘Legge F Margariti PA Lucidi A 2013Acta O-ncol2013,52,1:1
18Idiopathic recurrent pancreatitis:long-term results after ERCP,endoscopic sphincterotomy,or ursodeoxycholic acid treatment显示文摘Testoni PA Caporuscio S Bagnolo F 2000Am J Gastroenterol2000,95,:1
19Identication of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation显示文摘Torricelli F Brizzi L Bernabei PA 1993Ital J Anat Embryol1993,98,2:1
20International Autoim- mune Hepatitis Group Report :review of criteria for diagnosis of autoimmune hepatitis 显示文摘Mvarez F Berg PA Bianchi FB 1999J Hepatol1999,31,5:1
返回顶部 每页显示:
共55页 首页 上一页 第1页 下一页 末页 /55 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费